Truist raised the firm’s price target on Ovintiv (OVV) to $60 from $59 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s model with 2026 expectations. Truist sees sequentially higher estimated 2026 earnings and free cash flows based on minimally lower commodity prices, minimally higher production, flat costs, minimal asset degradation, and minimal to moderate operational efficiencies, adding that it sees commodity prices – oil and natural gas – remaining firmer this year than many investors currently expect.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.